Versant Capital Management’s Theravance Biopharma TBPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.69K | Sell |
425
-432
| -50% | -$4.77K | ﹤0.01% | 2177 |
|
|
2025
Q1 | $7.65K | Buy |
+857
| New | +$7.65K | ﹤0.01% | 1849 |
|
|
2021
Q2 | – | Sell |
-239
| Closed | -$5K | – | 1589 |
|
|
2021
Q1 | $5K | Hold |
239
| – | – | ﹤0.01% | 1046 |
|
|
2020
Q4 | $4K | Hold |
239
| – | – | ﹤0.01% | 1003 |
|
|
2020
Q3 | $3K | Hold |
239
| – | – | ﹤0.01% | 1014 |
|
|
2020
Q2 | $5K | Hold |
239
| – | – | ﹤0.01% | 865 |
|
|
2020
Q1 | $5K | Sell |
239
-13
| -5% | -$272 | ﹤0.01% | 792 |
|
|
2019
Q4 | $6K | Sell |
252
-56
| -18% | -$1.33K | ﹤0.01% | 892 |
|
|
2019
Q3 | $5K | Buy |
+308
| New | +$5K | ﹤0.01% | 967 |
|
|
2019
Q2 | – | Sell |
-10
| Closed | – | – | 1682 |
|
|
2019
Q1 | $0 | Buy |
+10
| New | – | ﹤0.01% | 1728 |
|